- Newest Levaquin Lawsuit Claimant Suffered Tendon Damage to Her Knee
- Mississippi Supreme Court Permits Drug Lawsuit to Continue in Original Venue – Fredericks v. Malouf
- Yaz Lawsuit Transferred to Illinois MDL
- Depression Treatment Study Finds Placebos Work Better Than Talk Therapy/Antidepressants for Treating Depression
- Third Levaquin Bellwether Case in Minnesota MDL
- Trial Ends in Levaquin Injury Lawsuit Filed by Patient Who Ruptured Both Achilles Tendons
- Study: Ruptured Tendons Can be Eased with Ankle Position
- Judge Herndon Orders First Bellwether Yaz Trial Postponed
- Manufacturer of Banned Painkiller Vioxx Settles Canadian Lawsuits for Up to C$37 Million
- Federal Study: 11 Percent of Population Taking Antidepressants Like Paxil
- Levaquin Lawsuit Joins Minnesota MDL
- Generic Reglan Lawsuit Dismissed
- Plaintiff Claims Misleading Marketing in Levaquin Lawsuit
- Trial Begins in Texas Lawsuit Alleging Manufacturer Fraudulently Promoted Antipsychotics
- Recently-dismissed Reglan Lawsuit May be Re-filed
- Yaz Lawsuit Headed for Statewide Coordination
- Studies Suggest Yaz Causes Hormonal Imbalances That May Worsen Yaz Side Effects
- Federal Judge Orders Mediation in Yaz Bellwether Case Set for Trial in Southern Illinois
- Paxil Affects Bone Health
- FDA Advisory Panel: No Yaz Recall, Just Stronger Warning
- Glaxo Loses Ruling in Paxil Mass Tort
- Nevada Supreme Court Upholds Denial of Change of Venue in Anesthetic Liability Case – Sicor v. Sacks
- FDA Bans Critic’s Right to Vote on Yaz in Panel Meeting
- India Stands to Profit from Patent Cliff that Includes Levaquin
- Yaz Gallbladder Lawsuit to Tag Along in Illinois MDL
- Bayer Asks Pennsylvania Supreme Court to Intervene in Philadelphia Yaz and Yasmin Lawsuits
- FDA Wants to Add Info to Yaz Labels
- Study: Foster Kids Overmedicated with Psychotropic Drugs
- Jury Awards $72 Million to Women Who Developed Breast Cancer After Taking Prempro
- Younger Patients Focus of New Levaquin Lawsuit
- Seniors More Susceptible to Adverse Side Effects from Prescription Medications
- Study Confirms SSRI Link to Birth Defects
- KV Pharmaceutical Will Pay $17 Million to Settle Claims of Fraud on Federal Health Care Programs
- Generic Reglan Plaintiffs Finally Catch a Break
- Bayer Emails Suggest Company Trying to Promote Off-label Yaz Uses
- Woman Claims Tendon Rupture After Taking Levaquin for 3 Months
- Lawsuit Hoping to Ban Reglan Use
- Levaquin Lawsuit Suggests J&J Targeted the Elderly
- Convicted Drunk Driver Cites Prescription Meds in Appeal
- Yaz Lawsuit Turns Up Evidence That Bayer Suggested Promoting It for Off-Label Uses
- Soldiers, Vets Dying After Taking Seroquel/Paxil/Klonopin Drug Cocktail
- Yet Another Study Confirms Yaz Blood Clots
- California Yaz Lawsuit Moved to MDL in Illinois
- Ninth Circuit Finds Amgen Made False Material Statements About Anemia Drugs – Connecticut Retirement Plans v. Amgen
- Glaxo Agrees to $3 Billion Settlement Over Drug Disputes
- First of the Bellwether Cases' Trial Date Scheduled
- Are Any Antidepressant Medications Safe?
- Arkansas Supreme Court Holds Husband Not Entitled to Proceeds of Stepchildren’s Vioxx Lawsuit – Bridges v. Shields
- Poor Economy Being Blamed for Jump in Antidepressant Use
- Levaquin Lawsuit Filed Against Ortho-McNeil
- One Yaz Lawsuit Alleges the Pill Caused Blindness
- Eighth Circuit Dismisses Hormone Replacement Therapy Cases as Time Barred in New York – Rick et al. v. Wyeth
- Drugging Too Common in America
- Antidepressants May Cause Nightmares
- Recent Ruling has Reglan Lawyers Trying to Negotiate Settlements with Generic Drug Makers
- Jury Finds for Pharmaceutical Company in New Jersey Levaquin Side Effects Lawsuit
- SSRIs Still Prescribed to Pregnant Women
- New Jersey Jury Finds Levaquin Warnings Acceptable
- Judge Awards $3 Million in Paxil Lawsuit
- Court Rules Nurse May Testify Within Medical Specialty in Pharmaceutical Liability Cases – Williams v. Baxter Healthcare Corp. et al.
- Pfizer Accused of Paying 'Administration Fees' to Pharmacists for Patient Information
- FDA’s Concerns About Yaz Blood Clots Continue
- Will the End-of-Summer Blues Increase Antidepressant Use?
- Kids and OCD: Will Doctors Prescribe Antidepressants?
- Eighth Circuit Allows Proposed Class Action for Drug Manufacturing Defects – LeFaivre v. KV Pharmaceutical et al.
- Free Yaz May Cause More Harm than Good
- Study: Antidepressants Taken with Blood Thinners May Cause More Bleeding After Heart Attacks for Some Patients
- Jury Awards More Than $3 Million in New Mexico Paxil Lawsuit
- Ninth Circuit Upholds Dismissal of Contact Lens Case Based on Medical Device Preemption – Degelmann v. Advanced Medical Optics
- What are the Differences Between Yaz and Yasmin?
- Study: Fetal Exposure to SSRIs Alters Neurobehavioral Development
- Efforts Underway to Cut Dementia Patients off Antipsychotic Drugs
- Allegations That GERD Drugs Caused Tardive Dyskinesia Dismissed Due to Supreme Court Rulings – Morris et al. v. Wyeth et al.
- Study Shows that SSRIs Taken with Anti-platelets Cause Bleeding in Heart Attack Patients
- Experts: You Can Still File Paxil Birth Defects Lawsuit
- FDA: Hyperkalemia is a Side Effect of Yaz
- Second Maker of Supposedly Sterile Wipes Recalls Products for Possible Contamination
- CDC Weighs in on Yaz Dangers for New Mothers
- Anal Atresia Yet Another Birth Defect Linked to Paxil
- Federal Circuit Denies Damages to Woman Claiming Injuries From Vaccine – Lombardi v. Secretary of HHS
- Vancouver Judge Rules: Glaxo Not Getting Plaintiff's Medical Records
- Supreme Court Ruling Won't Stop Reglan Lawsuits from Moving Forward
- The Public Citizen Pleas with FDA to Allow Generic Label Updates
- New Jersey Levaquin Trial Finally Begins
- Former Employee Alleges Drug Company Fired Him for Refusing to Validate Contaminated Drugs – Bazzi v. Tyco Healthcare Group
- Overseas Facility Inspections May Cost Generic Drug Makers Millions Annually
- Levaquin Tendon Ruptures not Limited to the Heel
- Pharmacist Blamed in Yaz Death
- Judge Herndon Seals Witness Production Order in Yaz MDL
- New Study Suggests Drug Ads Don’t Adhere to FDA Rules
- Judge Herndon Reinstates Dismissed Yasmin Lawsuit
- Second Circuit Upholds Summary Judgment for Eli Lilly in Zyprexa Lawsuit – Brown v. Noxubee General Hospital
- Two Families Afraid Effexor Killed their Newborns
- More Plaintiffs Joining New York Levaquin Lawsuit
- Second Circuit Punts Tolling Question in Fosamax Injury Case to Virginia Supreme Court – Casey et al. v. Merck
- Levaquin Lawsuits Keep Piling Up: Add Two More Plaintiffs to the List
- Supreme Court’s Blanket Judgement Has Yaz Lawyers Wondering if Ocella is Exempt from Lawsuits
- First New Jersey Levaquin Trial Almost Underway
- Study Shows Treating Heartburn May Extend Life of IPF Patients, But at What Cost?
- Tenth Circuit Reverses Summary Judgment Order in Prozac Murder Suicide Lawsuit – Rimbert v. Eli Lilly
- Program Now Offering Effexor Patients Help with Withdrawal Symptoms
- Health Canada Updates Reglan Labels to Warn of Tardive Dyskinesia
- Eighth Circuit Declines to Toll Statute of Limitations in Mirapex Gambling Lawsuit – Gazal v. Boehringer Ingelheim Pharmaceuticals et al.
- Family Attacks Health Canada Over Canadian Teen’s Suicide
- Many Now Wondering How Supreme Court Ruling Will Affect Reglan Settlements
- Study Shows Nursing Home Residents Taking Effexor More Likely to Fall Down
- FDA Adds Cardiovascular Risk Warning to Label of Anti Smoking Drug Chantix
- Rite Aid Sues Ranbaxy Over Generic Reglan
- Civil Lawsuit Claims Wyeth’s Effexor Patents Were Illegal
- Next Generation of Antidepressants Will Need Something New if They are to Compete for Sales After Patents Expire on First Generation SSRIs
- California Woman Files Levaquin Lawsuit
- North Carolina Man May Sue Drug Company in Its Home State When Suit Barred at Home – Mace v. Mylan Pharmaceuticals
- Supreme Court's Generic Reglan Decision Causes 'Total Shock and Disbelief'
- FDA Officially Identifies Pancreatitis as Yaz Side Effect
- Male Nurse Charged with Sexually Abusing Patient Taking Effexor
- Treating Doctors’ Testimony Insufficient in Medical Device Defect Case – Williams v. Mast Biosurgery USA
- Americans Make up the Largest Demand for Anti-anxiety Meds Like Paxil and Effexor
- Supreme Court Ruling Still Pending Over Whom is Liable in Reglan Lawsuits
- More Women Switching to IUDs as Their Birth Control Method
- Supreme Court Rules State Drug Tort Claims Preempted by Federal Drug Regulations – PLIVA Inc. v. Mensing
- Man Loses Levaquin Lawsuit Against J&J
- Early Levaquin Trials Looking Good For Plaintiffs So Far
- Americans Questioning the Safety of Antibiotics like Levaquin Because They Think They are Being Poisoned
- Reglan Settlements Likely to Depend on Patient Medical Histories
- Paxil Being Touted as a Possible Treatment for PMDD
- Generic Competition Set to Dig Into J&J Sales as FDA Approves 12 Levaquin Clones
- FDA Still Says Women Should Take Yaz
- Seventh Circuit Upholds Dismissal of Illinois Woman’s Yasmin Lawsuit – Walton v. Bayer Corp.
- Drug Watchdog Urging Yaz Victims to Contact Them
- Consumers Need “More for Less” as Skyrocketing Demand for Generic Drugs Shows
- FDA Orders New Safety Information on Diabetes Drug for Cancer and Pancreatitis Risk
- "Combat Stress” Causing More Soldiers to Take Antidepressants While Serving in Afghanistan
- Study of Paxil Released by the JAACAP Months Ago Finally Gets Retracted
- Nelson Woman Overdoses on Effexor
- Judge Tunheim Presiding Over Levaquin Lawsuits OKs Release of Confidential Schedin Documents
- Jury Awards $10 Million to Family of Girl Injured by Rare Reaction to Children’s Motrin
- Book Claims That Psychiatric Labels are Driven by Drug Companies
- Study Shows Switching to Generic Antidepressants Can Cause Relapse in Symptoms for Some Patients
- FDA Announces Safety Review of Yaz and Yasmin After Studies Show Blood Clot Risk
- Reglan Side Effects Are Similar to Those Suffered by Patients Taking Antipsychotics
- Yaz Blamed for Another Death as Mother of Dead Girl Files Suit
- Depressed Diabetics Beware! New Study Warns that Combination of Paxil and Pravachol Might Increase Your Blood Sugar
- Judge Carol Higbee to Preside Over 1,000 Reglan Lawsuits
- FDA Dramatically Curtails Availability of Avandia After Studies Show Heart Risks
- Swiss Appellate Court Rejects Bayer’s Attempt to Stop Media From Bashing Yaz
- Judicial Panel Agrees to Centralize Reglan Lawsuits Instead of MDL
- Another Yaz Lawsuit Filed by Mother of College Freshman Who Died of Blood Clot
- Another Generic Yaz Finally Reaches the Market
- Sales for Yaz Drop While Profits Rise
- Who Will Win the Generic Drug Debate?
- Federal Audit of Medicare Use Finds Dangerous Overuse of Atypical Antipsychotics
- Dr. Reddy’s and Wyeth Reach Settlement Over Effexor
- Alternatives to Levaquin
- Reglan Lawsuit in Illinois Jumps to 1,000 Litigants
- FDA Recalls Name Brand Version of Blood Thinner Warfarin for Too Much Strength
- U.S. Health Regulators Have Approved the Sale of Generic Effexor In India
- Research Shows that SSRI Drugs Like Paxil Linked to Breast Cancer
- Levaquin Lawsuits Status Conference Took Place Yesterday
- FDA Testing Proposed Simpler Prescription Drug Labels to Fight Overdoses and Misuse
- Supreme Court Judges Speak Out About Generic Reglan Lawsuits
- Pfizer Reaches Settlement with Orchid Chemicals over Generic Effexor Sales
- Reglan Defense Lawyers Argue Generic Manufacturers Didn’t Update Warning Labels
- Study Links Increase in Kidney Injuries to Diet Drug Already Known for Liver Damage
- Doctors' Warning: Taking Paxil During Pregnancy Gives 50% Chance of Babies Suffering from Birth Defects
- Study Shows Paxil More Likely to Cause Suicides in Severely Depressed People
- Glaxo Cuts Jobs Over Lawsuits and Poor Sales
- Ingredient in Over-the-Counter Teething Gel Linked to Deaths From Oxygen Deprivation
- Yet Another Side Effect Attributed to Reglan Use
- Yaz Side Effects Keeps Mounting; Many Wonder if Recall Will Ever Happen
- Yaz May Be Sold Over the Counter in DC: What's Wrong With This Picture?
- US Marshals Force Triad Alcohol Prep Pad Maker to Obey FDA Shutdown Order
- Galveston Woman Files Yaz Lawsuit
- April and May Will Finally Bring Levaquin Lawsuits Into The Courtroom
- Canadian Woman Seeks Class Action Status in Yaz Lawsuit
- What Causes Reglan-induced Blepharospasm?
- Bellwether Update: Yaz Plaintiffs Seeking More Time to Gather and Review Evidence
- New Black Box Warning Issued to Levaquin Amid Claims it Worsens Myasthenia Gravis
- Supreme Court Allows Lawsuit to Continue Over Failure to Disclose Zicam Problems
- Paxil- and Effexor-induced Tragedies the Subject of Panel Discussion in New York
- Study Shows Depression Can Worsen Arthritis Pain in the Knee
- Study Says Paxil and Effexor Among Top Ten Meds To Cause Violent Behavior
- FDA Wins Consent Decree With McNeil Over Unsolved Tainted Drug Problems
- Reglan: Parkinson's Disease May Not Be So Wrong A Diagnosis After All
- The Effexor Defense: Gary Michael Hilton is Convicted of Homicide
- Bellwether Update: Herndon Attends Status Conference in Illinois
- FDA Resumed Triad Inspections Only After Colorado Hospital Found Contamination
- Yaz Lawsuits Expected to Reach 25,000
- Yaz is Moving To Brazil
- Misdiagnosed Bipolar Disorder Leads to Sexual Assault of a Minor After Woman Takes Effexor
- FDA Issues Safety Warning That Stomach Acid Drugs May Cause Mineral Deficiency
- Understanding the Statute of Limitations for Filing Yaz Lawsuits
- Texas Law Firm Ready For First Paxil Birth Defects Trials to Happen in May
- Time's Up! Reglan Lawsuits Filed After February 26 Will Have Little Chance of Success
- Complaints About Contaminated Alcohol Wipes Growing After MSNBC Investigation
- Two Jersey Women Sue Bayer Amid Claims of Deceptive Advertising
- Louisiana Woman Files Reglan Lawsuit When Daughter Develops Tardive Dyskinesia
- Yaz the Focus of Marketplace Segment "Spinning the Pill"
- Study Finds Drop in Use of Antipsychotics for Dementia After Black Box Warning
- Vermont Getting $136,000 from Glaxo Settlement
- Are Mounting Yaz Lawsuit Filings Piling on Settlement Pressure?
- Are Mounting Yaz Lawsuit Filings Piling on Settlement Pressure?
- Avandia Manufacturer Implements FDA Requirement to Strictly Control Patient Access
- Academics Asking if Discredited Paxil Article should be Retracted
- Semi vs. Train: Train 1, Semi 1/2
- Glaxo Leader Asks Pharma Execs 'What's Going On?'
- Yet Another Yaz Lawsuit Against Bayer filed by Jersey Woman
- FDA Declines to Approve Third Diet Drug in Three Months for Safety Reasons
- Yaz Patents the Subject of Lawsuit Filed by Bayer Against Sun Pharmaceuticals
- New Study Helps Bayer Stand Stubbornly By Yaz
- Judge Ordered Bayer to Fly Execs to U.S. for Yaz Lawsuit Deposition
- Appeals Court Rules Drug Makers Can Be Sued Even When Labels Meet FDA Standards
- News Show 60 Minutes Airs Whistleblower Accusations Against Glaxo
- Glaxo Denies Retaliation Implications Made During 60 Minutes Interview
- Drug Injury Lawsuits Recap 2010: Hidden Side Effects Brought About Many Lawsuits in 2010
- FDA Orders Cap on Strength of Prescription Painkillers Containing Acetaminophen
- Schedin's Doctor Regrets His Role in Patient's Levaquin Injuries
- Supreme Court Agrees to Hear Appeals for Reglan Side Effects Case
- FDA Orders New Label for Powerful Painkiller After Several Reports of Overdose
- Bayer's New Beyaz Pill Not Fooling Anyone
- Bellwether Approach Used to Decide Which Yaz Lawsuits Will go to Court First
- Investors Feel Deceived and Sue Bayer Over Yaz/Yasmin
- Will First Levaquin Trial Loss Spark More Settlements From Johnson & Johnson?
- Artificial Hip Manufacturer Gets Second FDA Warning Letter for Sterilization Problems
- Effexor Linked To PPHN
- New Hampshire Wins $1.24 Million Lawsuit Against Glaxo
- Did Kickbacks Increase Levaquin Sales?
- Man Vows to Make the Manufacturers of Levaquin 'Pay' for His Injuries
- Should Seasonal Sufferers of Depression be Given Potentially-harmful Antidepressants?
- Suicide May be a New Side Effect of Yaz
- FDA Considers Withdrawing Cancer Drug Avastin for Safety Concerns, Lack of Efficacy
- Woman Tries to Meet the Statute of Limitations on Lawsuit Against Reglan After Being Misdiagnosed with Parkinson's
- Statute of Limitations Speeding Up Number of Reglan Suits Filed in New Jersey
- Lawyer Claims Johnson & Johnson Did Warn Patients About Risks Associated with Levaquin
- First Lawsuit on Antibiotic Levaquin Ends With $1.1 Million Verdict for Injured Man
- Lawsuit Charges that Makers of Levaquin Pushed Drug on Seniors
- Paxil Can Make Men Infertile
- Invisalign Maker Gets FDA Warning Letter for Failing to Report Allergic Reactions
- Paxil May Cause Cataracts
- Chances of Permanent Disorder from Taking Reglan Higher than Expected
- Miscarriages Twice as Likely for Women Taking Effexor
- First Gadolinium Trial Start Over MRI Health Risk Begins January 2011
- Surgery May Be Necessary to Correct Gallbladder Problems Caused by Yaz/Yasmin
- FDA Cites Tylenol Manufacturer Yet Again for Safety Failures at Puerto Rico Plant
- Lawyer Claims Makers of Levaquin Hid the Risks
- Solicitor General Wants Reglan Appeal Rejected
- Paxil Blamed for Higher Breast Cancer Death Toll
- Glaxo Coughs up $6 Million to Washington State
- FDA Pulls Painkillers From Market After Tests Confirm Fatal Heart Rhythm Problems
- Effexor May Cause Anorexia
- Trial Update: Glaxo Didn't Warn About Paxil Risks, Lawyer Claims
- FDA Recalls Powerful Fentanyl Pain Medication Patches Because of Overdose Risk
- Paxil's Off-label Use: Premature Ejaculation
- Paxil Serves no Purpose In The End
- Paxil Being Used for Weight Loss
- Supplement for Teething Infants Recalled Due to Poisonous Herbal Ingredient
- Glaxo Braces Itself for Forced Price Cuts Next Year
- Mylan Appealing Court Ruling to Allow Generic Paxil Sales
- Iron Replacement Drug Feraheme May Get Black Box Warning for Fatal Cardiac Events
- Physician Survey Shows How Avandia Restrictions Will Benefit Januvia, Victoza and Byetta
- New Birth Defects Warnings for Paxil
- GlaxoSmithKline Pays $750 Million for Selling Tainted and Ineffective Products
- Effexor Withdrawal Symptom is "Brain Zapping"
- What Reglan Means For Breastfeeding Mothers
- Levaquin - Labeling Issues
- FDA Cracks Down on Unapproved Uses for Chelation Drugs After Two Children Die
- Warnings for People Taking Boniva and Fosamax
- Accutane Causes Severe, Potentially Deadly Skin Reactions
- Osteoporosis Drugs May Cause Thigh Fractures
- Levaquin: Yes, You CAN Overdose
- FDA Warns Gilead Over HIV Treatment, Other Meds Produced in Substandard Plant
- Yaz Has a New Label
- Avandia Ordered Off the Shelves in Europe
- Why the FDA Will NOT Pull Avandia from Diabetes Patients
- Paxil: Mylan Inc. Granted Temporary Order Blocking Apotex
- After Long Debate, FDA Severely Restricts Use of Avandia in American Diabetics
- Reglan - This Story Sounds Familiar
- Avandia Decision Underscores New Culture of Openness at Federal Drug Regulator
- Effexor: The Quality of Risk
- Reglan - Child Develops Tardive Dyskinesia
- Levaquin: The list of side effects goes on and on
- Drugmakers Agree to Pay Huge Settlements for Illegally Marketing Drugs to Children
- Paxil - What a Shock! Another Generic Fight
- Effexor Awareness
- Yaz - Bayer's Compulsive Advertising
- FDA Doctor to Be Honored for Fighting Against Manufacturers of Dangerous Drugs
- Effexor - Who Owns What?
- Reglan - Underlying Problems
- Gadolinium Labeling Change - Risk of Nephrogenic Systemic Fibrosis
- Reglan - Discontent over Dyskinesia
- Meridia Weight Loss Pill Increases Patients' Risks for Heart Attacks and Strokes
- Paxil - Bad News All Around
- Levaquin - Michigan Lawsuits
- Yaz - New Suits Being Filed
- Effexor - More Side Effects
- Paxil - Withdrawal Difficulties
- Effexor - Antidepressants and Eye Damage
- Eli Lilly Seeks to Expand Cymbalta Market Despite Serious Risks to Life and Health
- Levaquin - Diminishing Returns
- Paxil – Research Faker Pleads Guilty
- Paxil and Effexor - Sympathetic Suits?
- FDA Issues Warning for Users of Seizure Drug About Risk of Brain Inflammation Meningitis
- Yasmin - Hard Data Hard to Get
- Reglan - Risk Categories
- Paxil, Effexor - Big Numbers, Big Deal
- Levaquin – 96-person Lawsuit Filed
- Patients Receive $198 Million Settlement in Case Alleging Seroquel Led to Diabetes
- One-third of All Studies are Left Completely Unpublished
- Mass Yaz Lawsuits
- Texan Woman Sues over Yaz
- Rheumatoid Arthritis Drug Arava Blamed for 14 Patient Deaths From Liver Failure
- Yasmin - Stroke Recovery
- Glaxo's Next Billion
- Effexor and Miscarriage Risk
- Another Johnson & Johnson Drug Manufacturing Plant Cited for Safety Failures
- Levaquin - Quinolones in the Long Term
- Reglan and Obesity in Children
- Reglan - New Lawsuit Heading to Trial
- FDA Dysfunction Leaves Avandia-Taking Patients to Watch Out for Their Own Safety
- New Levaquin Tendon Lawsuit
- Reglan - What Does the Black Box Say?
- Johnson & Johnson, McNeil Drugs Continue to Be Investigated and Recalled for Safety
- Reglan and the Statute of Limitations
- Levaquin - New Lawsuits Filed
- Yaz - Getting the Word Out
- Effexor XR to go Generic
- More Evidence Emerges of Increased Risk of Death and Disability From Avandia
- Paxil - Future Cases
- Reglan - No News?
- Reglan - the Reason for the Cases
- Yaz - Gianvi Labeling Woes
- Drug Used for Endometriosis and Prostate Cancer Linked With Misery for Patients
- Couple Files Reglan Suit
- Yaz: What is a Pulmonary Embolism?
- Paxil: Ethical Concerns
- Reglan: Tardive Dyskinesia Side Effects — You Can't Stop Them
- Levaquin - Varied Reactions
- Effexor - Living with PPHN
- Consumer Reports Warns Bone-Strengthening Drugs May Actually Cause Fractures
- Yaz: Something Wicked
- Yaz: What a Stroke Means
- FDA and House of Representatives Launch Investigations Into McNeil Recall
- Yaz: What You Don't Know
- Cymbalta and Birth Defects
- FDA Says Popular Acid Reflux Drugs Pose Risks of Fractures and Infection
- USA Piles on Pills
- Lexapro and PPHN
- Paxil Progressively Problematic
- Lupin Loses Levaquin Generic Fight
- FDA Cracks Down on Company Making Medications Contaminated With Insect Parts
- Paxil to be Tested on 7-year-olds
- Schwarz Found Not Responsible in Texas Reglan Case
- Beyond Clots - Yasmin and Gallbladder Symptoms
- FDA Slaps Black Box Warning on Hyperthyroidism Drug for Causing Severe Liver Damage
- Pharmaceutical Compliance Cops to Ride Along With Sales Reps
- Levaquin Lawsuits Moving Forward Slowly
- The Controversy of Yaz and Yasmin
- FDA and Congress Investigate Contamination and Other Problems at Johnson & Johnson
- Reglan Used for Infants
- FDA Rebukes Teva Pharmaceutical for Lax Manufacturing Practices
- Avandia Study May End Early Due to High Risk of Patient Heart Attack
- FDA Reprimands Drug Companies for Misrepresenting Drugs’ Safety
- Study Links Epilepsy and Depression Drugs to Suicidal Thoughts and Attempts
- Drug Manufacturer Admits It Ignored Duty to Warn FDA of Its Defective Products
- FDA Warns Patients That Cholesterol Drug Zocor Can Cause Muscle Damage
- FDA Adds Black Box Warning About Effectiveness to Label of Blood Thinner Plavix
- Radiation From CT Scans Poses a Special Cancer Risk to Children
- Dialysis Machine Recalled for Potential for Death or Serious Injury
- Senate Investigation of Avandia Shows Manufacturer Knew About Risks Years Ago
- FDA Puts Severe Restrictions on Use of Anemia Drugs in Cancer Patients
- Study Shows Common Antidepressant Lowers Effectiveness of Breast Cancer Drug
- FDA Issues Stronger Warning About Metabolic Problems for Teens Taking Zyprexa
- Study Shows Anti Obesity Drug Raises Risk of Heart Attack or Stroke in Heart Patients
- FDA Expands McNeil OTC Drug Recall, Rebukes Manufacturer for Yearlong Delay
- Reports Find Nursing Homes Use Antipsychotics Off-Label Despite Safety Warnings
- Analysis Finds Antidepressants Have Little or No Benefit for Mild Depression
- FDA Requests Further Studies of Diabetes Drug Due to Reports of Pancreatitis
- New Studies Show CT Scans Cause Tens of Thousands of Cancers Each Year
- FDA Updates Antidepressant Warning Label to Include Risk of Sudden Cardiac Death
- FDA Finds Greater Risk of Fatal Disorder From Certain MRI Drugs With Gadolinium
- Jury in Prempro Trial Awards Illinois Woman $6.3 Million for Link to Breast Cancer
- FDA Calls for New Labeling for Anesthetics Used in Post-Surgery Pain Pumps
- Study Confirms Serious Blood Clot Threat From Anemia Drugs for Cancer Patients
- Gadolinium Lawsuit Against GE Filed in St. Louis Circuit Court
- Diabetes Drug Prescribing Information Revised to Reflect Reports of Kidney Problems
- European Regulators Review Arthritis Drug Safety as FDA Announces New Case of Brain Infection
- Suspected Defects in Power Cords for Medical Devices Spark FDA Investigation
- FDA System for Tracking and Announcing Medical Device Recalls Faulted as Recalls Soar
- FDA Warns Doctors and Parents About Dosage Discrepancy for Liquid Form of Tamiflu
- FDA Orders Black Box Warning for Injected Sedative at Center of Supreme Court Case
- Memo Introduced at Paxil Trial Suggests Drug Company May Have Buried Negative Studies
- Drug Maker Pfizer to Pay Largest Criminal Fine Ever to Settle Allegations of Off Label Marketing
- Scientists Question Findings in Study of Asthma Drugs Funded by Drug Manufacturer
- FDA Announces Investigation Into Reports That Weight-Loss Drug Caused Liver Failure
- Manufacturer Recalls Generic Adderall Because of Oversized Pills Posing Risk of Heart Problems
- FDA Reviewing Data Suggesting Asthma Medication May Cause Heart Problems and Strokes
- Black Box Safety Warning Ordered for Certain Children’s Drugs That Raise Risk of Cancer
- FDA Requires Black Box Warning for Label of Gastrointestinal Drug Reglan
- Merck and Schering-Plough Pay $5.4 Million to Settle Drug Cover-Up Suits
- FDA Adds Black Box Warning to Painkillers Darvon and Darvocet Because of Risk of Fatal Overdose
- Anti-Smoking Drugs Chantix and Zyban Get Black Box Warning About Risk of Suicide and Mental Illness
- FDA Calls for Reduced Maximum Dosage of Common Pain Reliever Acetaminophen
- FDA Seizes Most of Generic Company Caraco's Drugs Due to Manufacturing Mistakes
- FDA Links Zicam to Permanent Sense of Smell Loss -- Other Homeopathic Products Under Scrutiny
- Zicam Linked to Loss of Smell and Withdrawn from the Market
- FDA Recommends Suicidal Behavior Precaution for Singulair and Other Asthma Meds
- New FDA Report Associates Liver Failure with Anti-Thyroid Drug
- Analysis Shows Risk of Perforated Stomach or Bowels Rises Sharply With Use of Cancer Drug
- Watchdog Group Asks FDA to Add Warning on Label of Constipation Drug That May Cause Miscarriage
- Heparin-Linked Deaths Spur Fears About Repeat of 2008 Contaminated Prescription Drug Recall
- FDA Announces Safety Recall of Diet Aid Hydroxycut Following Cases of Liver Damage and Death
- Hydroxycut Diet Aids Recalled After Warning
- Over-the-Counter Painkillers Must Carry Stronger Warnings of Potential Organ Damage, FDA Decides
- FDA Gets Court Order Barring Pharmaceutical Company From Selling Unapproved and Unsafe Drugs
- Congress Considering Restoring Patients’ Ability to File Defective Medical Device Lawsuits
- Psoriasis Medication Removed from U.S. Market After Link to Brain Infection
- Documents Show FDA Repeatedly Overruled Scientists’ Rejections in Menaflex Knee Device Approval
- Congress Considers Legislation to Reverse Supreme Court Decision on Defective Medical Device Lawsuits
- Unsealed Documents Show Pharmaceutical Company Buried Unfavorable Studies on Seroquel
- U.S. Supreme Court Rules FDA Approval Does Not Bar Pharmaceutical Injury Lawsuits
- FDA to Study Effects of TV Ads for Prescription Drugs on Consumers -- Missouri Pharmaceutical Liability Law Firm
- FDA Panel Recommends Davron and Darvocet Be Removed From Market -- St. Louis Defective Prescription Drug Lawyer
- FDA Recalls Dietary Supplement Containing Undeclared Controlled Substance -- St. Louis Dangerous Drug Attorney
- Troubled Missouri Drug Manufacturer Pulls Almost All Products From Market -- Southern Illinois Drug Injury Law Firm
- Prescription Painkiller Recalled Due to Potential for Dangerous Overdose -- St. Louis Dangerous Medication Law Firm
- Defibrillator Lawsuits Against Medtronic Dismissed--Missouri Medical Device Attorney
- Missouri to Receive $18 Million in Zyprexa Lawsuit -- St. Louis Defective Drugs Attorney
- Johnson & Johnson Recalls Duragesic Patch Painkillers Due to Overdose Potential -- Illinois Defective Prescription Drug Lawyer
- Heparin from China found to be contaminated with man-made chemical--defective drug attorney.
- FDA Warns Public to avoid 69 Brands of Dangerous Diet Pills -- Missouri Defective Medication Attorney
- Fluoroquinolone Antibiotics Such as Levequinn and Cipro Carry an Increased Risk of Tendon Rupture--Defective Drug Lawyer
- Two Bowel-Cleansing Drugs Linked to Severe Kidney Injury -- Illinois Dangerous Drugs Attorney
- Avastin Linked to Blood Clots and Cancer Drug According to a Recent Medical Study-- Missouri Defective Drug Law Firm
- Drug Maker Wyeth Under Fire for Use of Ghostwriters -- St. Louis Defective Drug Lawyers
- Cardiologist Warns of Lax FDA Regulations for New Implanted Defibrillator -- St. Louis Defective Medical Device Lawyer
- Advisory Panel Recommends Ban of Two Asthma Drugs- Serevent and Foradil--Defective Drug Lawyer
- Trasylol Dangers Confirmed in Latest Study
- Duragesic Pain Patch Case-Jury Awards Nearly $16.6M in Damages
- Mechanical Heart Pump Recalled
- Artificial Blood Raises Risk of Death, Heart Attack
- Trasylol Supplies Finally Pulled by Bayer
- Canadian Trasylol Study Results Announced
- Top FDA Staff Opposed the Bush Administration's Attempt To Shield Drug Companies
- Fen-Phen Trial Results in $3 Million Jury Verdict
- Pfizer Agrees to Settle Celebrex and Bextra Claims for $894 Million
- Transvaginal Surgical Mesh is the Subject of a FDA Public Health Notification
- Deaths Linked to Anti-Anemia Drugs Probed
- Supreme Court to Decide Appeal Filed by Wyeth against Amputee
- Medtronic Infusion Pump Recalled by the FDA
- Trasylol Pulled From the Market and Can Only be Used for Investigational Use
- Trasylol Pulled From the Market and Can Only be Used for Investigational Use
Contact
(877) 678-3400
Free Initial Consultation
(877) 678-3400
Free Initial Consultation
Connect
Carey, Danis & Lowe Blogs
Search this Blog
Recent Entries
- February 3, 2012 3:06 AM
Newest Levaquin Lawsuit Claimant Suffered Tendon Damage to Her Knee While most people associate tendon ruptures with Achilles tendons, an... - February 2, 2012 10:30 PM
Mississippi Supreme Court Permits Drug Lawsuit to Continue in Original Venue – Fredericks v. Malouf As a dangerous drug lawyer, I was pleased to see... - February 1, 2012 4:01 AM
Yaz Lawsuit Transferred to Illinois MDL When plaintiff Laura Tenorio filed her Yaz lawsuit in the... - January 30, 2012 4:37 AM
Depression Treatment Study Finds Placebos Work Better Than Talk Therapy/Antidepressants for Treating Depression A recent study on depression treatments has revealed something that... - January 27, 2012 3:59 AM
Third Levaquin Bellwether Case in Minnesota MDL A recent lawsuit that focused on Levaquin tendon ruptures is...
Archives
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
Legal Blogs
- Drug Injury Attorney Blog (Carey, Danis & Lowe)